200 related articles for article (PubMed ID: 28675044)
21. Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.
Banik S; Mansour AA; Suresh RV; Wykoff-Clary S; Malik M; McCormick AA; Bakshi CS
PLoS One; 2015; 10(6):e0130858. PubMed ID: 26098553
[TBL] [Abstract][Full Text] [Related]
22. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.
Czapar AE; Zheng YR; Riddell IA; Shukla S; Awuah SG; Lippard SJ; Steinmetz NF
ACS Nano; 2016 Apr; 10(4):4119-26. PubMed ID: 26982250
[TBL] [Abstract][Full Text] [Related]
23. Serum albumin 'camouflage' of plant virus based nanoparticles prevents their antibody recognition and enhances pharmacokinetics.
Pitek AS; Jameson SA; Veliz FA; Shukla S; Steinmetz NF
Biomaterials; 2016 May; 89():89-97. PubMed ID: 26950168
[TBL] [Abstract][Full Text] [Related]
24. Tobacco Mosaic Virus-Functionalized Mesoporous Silica Nanoparticles, a Wool-Ball-like Nanostructure for Drug Delivery.
Marín-Caba L; Chariou PL; Pesquera C; Correa-Duarte MA; Steinmetz NF
Langmuir; 2019 Jan; 35(1):203-211. PubMed ID: 30576145
[TBL] [Abstract][Full Text] [Related]
25.
Karan S; Durán-Meza AL; Chapman A; Tanimoto C; Chan SK; Knobler CM; Gelbart WM; Steinmetz NF
Mol Pharm; 2024 Jun; 21(6):2727-2739. PubMed ID: 38709860
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.
Petukhova NV; Gasanova TV; Stepanova LA; Rusova OA; Potapchuk MV; Korotkov AV; Skurat EV; Tsybalova LM; Kiselev OI; Ivanov PA; Atabekov JG
Curr Pharm Des; 2013; 19(31):5587-600. PubMed ID: 23394564
[TBL] [Abstract][Full Text] [Related]
27. Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin.
Li ZH; Zhang Q; Wang HB; Zhang YN; Ding D; Pan LQ; Miao D; Xu S; Zhang C; Luo PH; Naranmandura H; Chen SQ
Invest New Drugs; 2014 Feb; 32(1):75-86. PubMed ID: 23903896
[TBL] [Abstract][Full Text] [Related]
28. Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles.
Chariou PL; Wang L; Desai C; Park J; Robbins LK; von Recum HA; Ghiladi RA; Steinmetz NF
Macromol Biosci; 2019 May; 19(5):e1800407. PubMed ID: 30721575
[TBL] [Abstract][Full Text] [Related]
29. Peripheral neuropathy with microtubule inhibitor containing antibody drug conjugates: Challenges and perspectives in translatability from nonclinical toxicology studies to the clinic.
Stagg NJ; Shen BQ; Brunstein F; Li C; Kamath AV; Zhong F; Schutten M; Fine BM
Regul Toxicol Pharmacol; 2016 Dec; 82():1-13. PubMed ID: 27773754
[TBL] [Abstract][Full Text] [Related]
30. Sortase A-Generated Highly Potent Anti-CD20-MMAE Conjugates for Efficient Elimination of B-Lineage Lymphomas.
Pan L; Zhao W; Lai J; Ding D; Zhang Q; Yang X; Huang M; Jin S; Xu Y; Zeng S; Chou JJ; Chen S
Small; 2017 Feb; 13(6):. PubMed ID: 27873460
[TBL] [Abstract][Full Text] [Related]
31. Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol Efflux.
Shin MD; Ortega-Rivera OA; Steinmetz NF
Bioconjug Chem; 2022 Oct; 33(10):1922-1933. PubMed ID: 36191144
[TBL] [Abstract][Full Text] [Related]
32. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
33. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M
J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298
[TBL] [Abstract][Full Text] [Related]
34. Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles.
Atabekov J; Nikitin N; Arkhipenko M; Chirkov S; Karpova O
J Gen Virol; 2011 Feb; 92(Pt 2):453-6. PubMed ID: 20980527
[TBL] [Abstract][Full Text] [Related]
35. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
36. Bioinspired Artificial Tobacco Mosaic Virus with Combined Oncolytic Properties to Completely Destroy Multidrug-Resistant Cancer.
Wu H; Zhong D; Zhang Z; Li Y; Zhang X; Li Y; Zhang Z; Xu X; Yang J; Gu Z
Adv Mater; 2020 Mar; 32(9):e1904958. PubMed ID: 31961987
[TBL] [Abstract][Full Text] [Related]
37. Tobacco mosaic virus movement protein complements a Potato spindle tuber viroid RNA mutant impaired for mesophyll entry but not mutants unable to enter the phloem.
Wu J; Bisaro DM
PLoS Pathog; 2022 Dec; 18(12):e1011062. PubMed ID: 36574436
[TBL] [Abstract][Full Text] [Related]
38. Milestones in the research on tobacco mosaic virus.
Harrison BD; Wilson TM
Philos Trans R Soc Lond B Biol Sci; 1999 Mar; 354(1383):521-9. PubMed ID: 10212931
[TBL] [Abstract][Full Text] [Related]
39. Tobacco mosaic virus (TMV) and potato virus X (PVX) coat proteins confer heterologous interference to PVX and TMV infection, respectively.
Bazzini AA; Asurmendi S; Hopp HE; Beachy RN
J Gen Virol; 2006 Apr; 87(Pt 4):1005-1012. PubMed ID: 16528051
[TBL] [Abstract][Full Text] [Related]
40. Novel roles for well-known players: from tobacco mosaic virus pests to enzymatically active assemblies.
Koch C; Eber FJ; Azucena C; Förste A; Walheim S; Schimmel T; Bittner AM; Jeske H; Gliemann H; Eiben S; Geiger FC; Wege C
Beilstein J Nanotechnol; 2016; 7():613-29. PubMed ID: 27335751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
